LU83727A1 - Hydrates cristallins de tosylate de(d-alpha-amino alpha-phenylacetamido)-6 penicillanate de dioxo-1,1 penicillanoyloxymethyle utiles comme medicaments antimicrobiens et procedes de leur preparation - Google Patents

Hydrates cristallins de tosylate de(d-alpha-amino alpha-phenylacetamido)-6 penicillanate de dioxo-1,1 penicillanoyloxymethyle utiles comme medicaments antimicrobiens et procedes de leur preparation Download PDF

Info

Publication number
LU83727A1
LU83727A1 LU83727A LU83727A LU83727A1 LU 83727 A1 LU83727 A1 LU 83727A1 LU 83727 A LU83727 A LU 83727A LU 83727 A LU83727 A LU 83727A LU 83727 A1 LU83727 A1 LU 83727A1
Authority
LU
Luxembourg
Prior art keywords
tosylate
amino
penicillanoyloxymethyl
phenylacetamido
compound according
Prior art date
Application number
LU83727A
Other languages
English (en)
French (fr)
Inventor
Wagn O Godtfredsen
Welf Daehne
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of LU83727A1 publication Critical patent/LU83727A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU83727A 1980-10-31 1981-10-30 Hydrates cristallins de tosylate de(d-alpha-amino alpha-phenylacetamido)-6 penicillanate de dioxo-1,1 penicillanoyloxymethyle utiles comme medicaments antimicrobiens et procedes de leur preparation LU83727A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8035156 1980-10-31
GB8035156 1980-10-31

Publications (1)

Publication Number Publication Date
LU83727A1 true LU83727A1 (fr) 1982-05-07

Family

ID=10517019

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83727A LU83727A1 (fr) 1980-10-31 1981-10-30 Hydrates cristallins de tosylate de(d-alpha-amino alpha-phenylacetamido)-6 penicillanate de dioxo-1,1 penicillanoyloxymethyle utiles comme medicaments antimicrobiens et procedes de leur preparation

Country Status (26)

Country Link
US (1) US4831025A (sv)
JP (1) JPS57126493A (sv)
KR (1) KR870001982B1 (sv)
AT (1) AT373893B (sv)
AU (1) AU543870B2 (sv)
BE (1) BE890938A (sv)
CA (1) CA1180696A (sv)
CH (1) CH647527A5 (sv)
DE (1) DE3143219A1 (sv)
DK (1) DK154219C (sv)
ES (1) ES8206531A1 (sv)
FI (1) FI813331L (sv)
FR (1) FR2493322B1 (sv)
GB (1) GB2114969B (sv)
GR (1) GR75369B (sv)
IE (1) IE51640B1 (sv)
IL (1) IL64009A (sv)
IT (1) IT1193735B (sv)
LU (1) LU83727A1 (sv)
NL (1) NL8104938A (sv)
NO (1) NO813683L (sv)
NZ (1) NZ198622A (sv)
PH (1) PH17820A (sv)
PT (1) PT73913B (sv)
SE (1) SE452322B (sv)
ZA (1) ZA817091B (sv)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432987A (en) * 1982-04-23 1984-02-21 Pfizer Inc. Crystalline benzenesulfonate salts of sultamicillin
PH20068A (en) * 1982-12-06 1986-09-18 Pfizer Process and intermediates for sultamicillin and analogs
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
ES2161602B1 (es) * 1999-04-08 2003-02-16 Asturpharma S A Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina.
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
CA2400784C (en) * 2000-02-24 2009-05-19 Advanced Pharma, Inc. Therapeutic product, use and formulation thereof
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
WO2001062195A1 (en) * 2000-02-24 2001-08-30 Advancis Pharmaceutical Corporation Antibiotic and antifungal compositions
US6638532B2 (en) 2000-02-24 2003-10-28 Advancis Pharmaceutical Corp. Tetracycline—doxycycline antibiotic composition
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US7105174B2 (en) * 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US7157095B2 (en) * 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
WO2004104022A2 (en) * 2003-05-16 2004-12-02 The General Hospital Corporation Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin a3), inhibitors thereof and methods of use thereof
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
WO2007004239A1 (en) * 2005-07-06 2007-01-11 Morepen Laboratories Limited New polymorphic form of sultamicillin tosylate and a process therefor
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2014014364A1 (en) 2012-07-17 2014-01-23 Bayer New Zealand Limited Injectable antibiotic formulations and their methods of use
MY172561A (en) 2012-07-17 2019-12-03 Bayer New Zealand Ltd Injectable antibiotic formulations and their methods of use
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1532222A (fr) * 1963-10-28 1968-07-12 Bristol Myers Co Procédé de préparation de dérivés de la pénicilline
KR830001903B1 (ko) * 1979-02-13 1983-09-19 레오 파마슈티칼 프로덕츠 리미티드 페니실란산유도체의 제조방법
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate

Also Published As

Publication number Publication date
ATA447781A (de) 1983-07-15
PH17820A (en) 1985-01-07
PT73913A (en) 1981-11-01
DK472181A (da) 1982-05-01
AU543870B2 (en) 1985-05-09
ES506751A0 (es) 1982-08-16
IE51640B1 (en) 1987-01-21
GR75369B (sv) 1984-07-13
AU7636581A (en) 1982-05-06
US4831025A (en) 1989-05-16
DK154219C (da) 1989-03-20
JPS57126493A (en) 1982-08-06
BE890938A (fr) 1982-04-30
GB2114969B (en) 1985-02-20
CA1180696A (en) 1985-01-08
KR830007671A (ko) 1983-11-04
ZA817091B (en) 1982-10-27
DE3143219C2 (sv) 1990-05-17
IL64009A0 (en) 1982-01-31
KR870001982B1 (ko) 1987-10-24
NZ198622A (en) 1985-07-12
DE3143219A1 (de) 1982-08-12
NO813683L (no) 1982-05-03
AT373893B (de) 1984-02-27
IT8168383A0 (it) 1981-10-23
FR2493322B1 (fr) 1986-06-13
CH647527A5 (de) 1985-01-31
DK154219B (da) 1988-10-24
IL64009A (en) 1984-09-30
SE452322B (sv) 1987-11-23
ES8206531A1 (es) 1982-08-16
SE8106404L (sv) 1982-05-01
GB2114969A (en) 1983-09-01
NL8104938A (nl) 1982-05-17
PT73913B (en) 1984-05-29
JPH027957B2 (sv) 1990-02-21
IT1193735B (it) 1988-08-24
FI813331L (fi) 1982-05-01
FR2493322A1 (fr) 1982-05-07
IE812361L (en) 1982-04-30

Similar Documents

Publication Publication Date Title
LU83727A1 (fr) Hydrates cristallins de tosylate de(d-alpha-amino alpha-phenylacetamido)-6 penicillanate de dioxo-1,1 penicillanoyloxymethyle utiles comme medicaments antimicrobiens et procedes de leur preparation
LU82164A1 (fr) -lactames derives de l acide penicillanique, leur preparation et leurs utilisations therapeutiques
FR2511679A1 (fr) Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent
BE883390A (fr) Derives de l'acide penicillanique utiles comme medicaments, compositions therapeutiques les contenant et procedes de leur preparation
CA1300133C (fr) Benzimidazoles et imidazopyridines sulfonamides, leur preparation et leurapplication en tant que medicaments
LU83672A1 (fr) Napsylate de(d-alpha-amino alpha-phenylacetamido)-6 penicillanate de dioxo-1,1 penicillanoyloxymethyle cristallin et ses formes hydratees,leurs procedes de preparation et des medicaments antimicrobiens les contenant comme produits actifs
FR2463143A1 (fr) Nouveaux 7-phenyl-(1,2,4) - triazolo-(4,3-c) - pyrimidine-5-yl-amines et amides 8-substitues, utiles notamment comme diuretiques, et leur procede de preparation
FR2499981A1 (fr) Acides amino-2 halogenobenzoyl-3 methylphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques
FR2610628A2 (fr) Nouveaux derives de l'acide 1-dethia 2-thia cephalosporanique, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
BE897068A (fr) Nouveau derive de la pyrazolo [1,5-a] pyridine sa preparation et les compositions pharmaceutiques qui les contiennent
CA1140155A (fr) PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU 1.alpha.,25-DIHYDROXY CHOLECALCIFEROL
JPH0560478B2 (sv)
LU82163A1 (fr) Nouveaux derives d'acide penicillanique utile notamment comme antibiotiques et leurs procedes de preparation
LU82333A1 (fr) Preparation des derives hydroxyles de l'isopropyl-amino-pyrimidine
GB2084572A (en) 1,1-Dioxopenicillanoyloxymethyl 6-(D- alpha -amino- alpha -phenylacetamido)penicillanate napsylate
FR2548180A1 (fr) Amides d'acides carboxyliques et leurs derives, leur preparation et leur application en therapeutique
WO1985005103A1 (fr) Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant
BE862019R (fr) Nouveaux derives de la vincamine, leur preparation et leur application comme medicaments
FR2643264A1 (fr) Trifluoromethoxy-5 benzimidazolamine-2, procede pour sa preparation et medicaments la contenant
BE881677A (fr) Nouveaux derives d'acide penicillanique utile notamment comme antibiotiques et leurs procedes de preparation
BE886301A (fr) Nouveaux antibiotiques, leur preparation et leur utilisation
BE564105A (sv)
BE721515A (sv)